PS945 KTE-X19, AN ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY, IN ADULT PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: END OF PHASE 1 RESULTS OF ZUMA-3

Authors :: Bijal D. Shah
Armin Ghobadi
William B. Donnellan
William G. Wierda
Martha Arellano
Maria R. Baer
Armen Mardiros
Lovely Goyal
John M. Pagel
Remus Vezan
T. Shen
Olalekan O. Oluwole
Kristen M. O'Dwyer
Yi Lin
Rajul K. Jain
Houston Holmes
J.H. Park
Aaron C Logan
Michael R. Bishop
Ryan D. Cassaday
Source :: HemaSphere. 3:426
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.

Subjects :: Adult patients
business.industry
Anti cd19
Lymphoblastic Leukemia
Relapsed refractory
Cancer research
Medicine
Chimeric Antigen Receptor T-Cell Therapy
Hematology
business

Full Text Access

Tools